Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abuse Liability of VLN Cigarettes vs Gum and Usual Brand
NCT03559751Phase 1Completed
- Sponsor
- 22nd Century Group
- Start
- Apr 2018
- Primary completion
- Sep 2018
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial (3 arms), sponsored by 22nd Century Group. Primary endpoints: Maximum Reduction in Urge to Smoke at 3 days and Maximum Pleasantness at 3 days. Started Apr 2018; status: completed.
Beyond the preview
Go deeper on NCT03559751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03559751.